Cardiac Surgery | Links Medicus Free Medical News & Perspectives

Our latest study, "Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017," was published yesterday in @LancetChildAdol. Read the full study online: https://t.co/XEbz4aQFzr pic.twitter.com/SO6j7LX4V4

— IHME at UW (@IHME_UW) January 22, 2020

Summary: Current AATS Guidelines on Surgical Treatment of Infective Endocarditis

23 Jan, 2020 | 01:54h | UTC

Current AATS guidelines on surgical treatment of infective endocarditis – Annals of Cardiothoracic Surgery (free)

Original Guideline: 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary (free)

Review: New‐onset Postoperative Atrial Fibrillation After Heart Surgery

21 Jan, 2020 | 01:04h | UTC

New‐onset postoperative atrial fibrillation after heart surgery – Acta Anaesthesiologica Scandinavica (free)

ACC/AHA Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease

12 Jan, 2020 | 21:29h | UTC

ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease – Journal of the American College of Cardiology (free)

Commentaries: Appropriate Use Criteria for Imaging of Congenital Heart Disease Patients: Key Points – American College of Cardiology (free) AND New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease – TCTMD (free)

[Abstract Only] Study: Hepatitis C–positive Donors are a Viable Option for Heart Transplant

9 Jan, 2020 | 01:18h | UTC

Expanding Heart Transplant in the Era of Direct-Acting Antiviral Therapy for Hepatitis C – JAMA Cardiology (link to abstract – $ for full-text)

Commentaries: Hepatitis C-positive donors a viable option to expand heart donor pool – Vanderbilt University Medical Center (free) AND Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C – 2 Minute Medicine (free)

Related Studies: Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients (link to abstract and commentaries) AND Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients (link to abstract and commentaries) AND Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients (link to abstract and commentaries) AND Favorable 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys (link to abstract and commentaries)

[Abstract Only] Randomized Trial: Angioplasty NOT Non-inferior to CABG for the Treatment of Unprotected Left Main Stenosis

5 Jan, 2020 | 14:19h | UTC

Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial – The Lancet (link to abstract – $ for full-text)

Commentary: NOBLE at 5 Years: New Data Favor CABG for Left Main Disease – TCTMD (free)

Related Commentary on Twitter

NEW: Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial https://t.co/T9a6n7CvFp pic.twitter.com/Mw2KdsBQfV

— The Lancet (@TheLancet) December 23, 2019

Randomized Trial: Angiotensin-II Receptor Blockade Reduces the Rate of Aortic Dilatation in Patients with Marfan Syndrome

12 Dec, 2019 | 08:24h | UTC

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial – The Lancet (free)

Invited Commentary: Angiotensin-II receptor blockade in Marfan syndrome – The Lancet (free)

Related Commentary on Twitter

NEW—Irbesartan is associated with a reduction in the rate of aortic dilatation in children and young adults with #Marfansyndrome and could reduce the incidence of aortic complications: finding from AIMS, double-blind, placebo-controlled randomised trial https://t.co/uVUWOC062A pic.twitter.com/FPiph5RcJu

— The Lancet (@TheLancet) December 11, 2019

BBC Investigation on the Reporting of the EXCEL Trial Raises Concerns Over the Safety of Stents for Left Main Disease in Patients at Low Risk for Surgery

11 Dec, 2019 | 08:19h | UTC

Surgeons withdraw support for heart disease advice – BBC (free)

YouTube Video: European guidelines on heart disease under review – BBC Newsnight (free)

Commentary: EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up – TCTMD (free)

Related Commentary on Twitter

Wow! Super 🔥🔥🔥🔥 breaking story!

Reanalysis of EXCEL using Universal Definition of MI would have changed results substantially.

Taggart may be vindicated.

H/t @MedCrisis @drjohnm https://t.co/Yu7qKuiBdV

— Venk Murthy (@venkmurthy) December 9, 2019

ASH Guideline: Prevention of Venous Thromboembolism in Surgical Hospitalized Patients

5 Dec, 2019 | 11:29h | UTC

American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients – Blood Advances (free)

Consensus Document: How to Prevent, Diagnose, and Treat Cardiac Implantable Electronic Device Infections

26 Nov, 2019 | 08:21h | UTC

European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) (free)

#AHA19 – Randomized Trial: Phosphodiesterase 5 inhibitor Improves Exercise Capacity in Patients Who Have Undergone the Fontan Procedure

19 Nov, 2019 | 08:45h | UTC

Results of the Fontan Udenafil Exercise Longitudinal (FUEL) Trial – Circulation (free for a limited period)

Commentaries: Teens with Heart Disease Improve Exercise Capacity in Large Clinical Trial – Children’s Hospital of Philadelphia (free) AND Pediatric drug trial finds benefit in teens with heart defect – NIH News Releases (free)

#AHA19 – Just Presented at the 2019 American Heart Association Annual Meeting

Related Commentary on Twitter

FUEL Trial- udenafil did not improve peak VO2, but did positively impact measures of exercise performance in pts w/FONTAN @PHNresearch @nih_nhlbi @HeartCare4Kids @ChildrensPhila #CircAHA19 #AHA19 #AHAJournals https://t.co/Kmt9GFASZR pic.twitter.com/WV0NITTg7y

— Circulation (@CircAHA) November 17, 2019

#AHA19 – [Not Published Yet] Landmark ISCHEMIA Trial: A Routine Invasive Strategy Does Not Reduce Cardiovascular Events in Patients with Stable Coronary Artery Disease

18 Nov, 2019 | 01:13h | UTC

Commentaries: International Study of Comparative Health Effectiveness With Medical and Invasive Approaches – ISCHEMIA – American College of Cardiology (free) AND ISCHEMIA Trial Examines Invasive vs. Conservative Strategy in SIHD Patients – American College of Cardiology (free) AND ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events – TCTMD (free) AND Surgery for Blocked Arteries Is Often Unwarranted, Researchers Find – The New York Times (free) AND ISCHEMIA Trial Finds No Evidence of Lower Cardiac Event Rates in Patients Treated with Heart Procedures, but Better Quality of Life – PR Newswire (free) AND Big study casts doubt on need for many heart procedures – Associated Press (free) AND Stents no better than drugs for many heart patients: U.S. study – Reuters (free) AND Stents, bypass surgery show no benefit in heart disease mortality rates among stable patients – Stanford Medicine (free)

#AHA19 – Just Presented at the 2019 American Heart Association Annual Meeting

#AHA19 – [Abstract Only] Randomized Trial: Early Surgery Improves Outcomes in Asymptomatic Patients with Very Severe Aortic Stenosis

18 Nov, 2019 | 01:09h | UTC

Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: RECOVERY Finds Early Surgery Beneficial For Asymptomatic Severe AS Patients – American College of Cardiology (free) AND Randomized Comparison of Early Surgery Versus Conventional Treatment in Very Severe Aortic Stenosis – RECOVERY – American College of Cardiology (free) AND Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY – TCTMD (free)

#AHA19 – Just Presented at the 2019 American Heart Association Annual Meeting

Related Commentary on Twitter

At a median of 6 years of follow-up, operative mortality or CV death occurred less frequently in asymptomatic patients with very severe aortic stenosis who received early valve replacement surgery than in those conservatively managed. #AHA19 https://t.co/hcQeoRqseJ

— NEJM (@NEJM) November 16, 2019